Wealth advisors have a name for the conversation that goes nowhere. They call it the concentration paradox: a client holds a single stock position worth more than the rest of their portfolio combined, the advisor flags the risk, and the client nods and does nothing. Not because they don’t understand the math. Because the position isn’t a mistake to them. It’s the proof of everything they did right.
That instinct is correct more often than the industry gives it credit for. A founder who held shares through a decade of building something real isn’t behaving irrationally by wanting to keep holding them. Neither is an executive whose comp structure tied their net worth to a company they still believe in. The conviction that created the wealth doesn’t expire just because a financial plan says it’s time to diversify.
The problem is that almost every tool built to address concentration asks the holder to give that conviction up.
Sell the stock outright and you’ve solved the concentration problem by eliminating the upside along with the risk, and triggered a tax bill in the process. Run a tender offer and you’re at the mercy of company timing, pricing, and eligibility rules you don’t control. Contribute shares to an exchange fund and you’ve traded a concentrated position for a diversified one you didn’t choose, locked up for years. Each of these is a legitimate tool. None of them lets a holder keep what they actually want to keep: ownership of the thing they built, and the option to keep believing in it.
This is the gap that limited-recourse, equity-backed lending fills, and it’s worth being precise about why it’s structurally different rather than just another item on the same list. A loan against a single public position, properly structured, doesn’t ask the borrower to choose between liquidity and conviction. The shares stay in a custodial account in the borrower’s name. Beneficial ownership doesn’t move. Appreciation still belongs to the holder. The lender’s recourse is contractually limited to the pledged collateral, not the borrower’s other assets, which means the downside is bounded in a way that a personal guarantee or a standard margin facility never is.
That distinction matters more than it gets credit for. Most borrowers don’t fully grasp how much recourse they’ve actually signed up for in a conventional structure until something goes wrong with it. A margin call on a standard brokerage facility doesn’t stop at the pledged shares. A limited-recourse facility, built correctly, does.
None of this means lending is the right answer for every concentrated holder. Some people should sell. Some should diversify gradually through a multi-year plan. The point isn’t that credit beats every other option. The point is that the advisory conversation around concentration has been framed as a binary between holding everything and giving something up, when a third path exists that doesn’t force that trade. The wealth management industry has been slow to talk about it clearly, in part because it doesn’t fit neatly into a typical advisory practice’s toolkit.
The shareholders who benefit most from understanding this are usually the ones who’ve already had the first version of this conversation and walked away from it unsatisfied. If diversification has been recommended and the recommendation hasn’t landed, the more useful question isn’t whether the advice was right. It’s whether the conversation considered the full range of structures available, or stopped at the ones already on the shelf.
